| INTRODUCTION
A principal characteristic of the JECP's work during the last quarter century has been the sustained, systematic analysis and critique of the EBM thesis, with unrelenting calls for the leaders of EBM to embrace an authentic scholarship and properly engage with their critics. In adopting this approach, the Journal has been the preeminent contributor to the global debate on EBM, forcing the initial 1992 EBM thesis 1 through serial reconstitutions of its philosophy and method. As a consequence, incremental shifts of EBM away from scientistic reductionism towards the embrace of the complex in clinical practice 2, 3 have taken place, albeit at glacial speed. The ill-considered claim for an EBM-mediated 'paradigm shift' has been relegated to the formaldehyde of medical history, 4 the hallowed EBM 'hierarchy of evidence'
has been rejected in favour of more "sophisticated" constructs, [5] [6] [7] and explicit references to individual patient values and preferences have become a recurring feature of recent EBM publications. 8, 9 Despite this significant progress, EBM has taken only the first few tentative steps in the direction of a properly humanistic approach to care, with some proponents of EBM doing so with a degree of enthusiasm, and others appearing more grudging. The question may therefore be asked: 'EBM -2018. Quo Vadis?' EBM, from its inception, attempted to reduce the clinical encounter to a guidelines-mediated, management-driven process, focussed on the diseased part, not the integral whole. [10] [11] [12] But as the 20 th Century of Biomedicine has given way to the 21 st Century of the Patient, 13 the highly formulaic approach of EBM has been increasingly confronted by the challenges posed by the dramatic increases in the incidence and prevalence of the chronic, co-and multimorbid, socially complex illnesses. [14] [15] [16] [17] [18] [19] Patients with these conditions present for assistance not as a collection of organ systems, but rather as integral human beings with narratives, values, preferences, psychology and emotionality. Understanding these patients' conditions involves understanding their cultural, social and economic situation, spiritual and existential concerns, their possible difficulties with sexual, relational and work functioning, their possible alcohol and substance abuses and addictions, worries, anxieties, fears, hopes and ambitions -and more. 20 To focus on pathophysiology alone, in accordance with EBM's foundationalist tenets, is to ignore the multidimensional impacts of the lived experience of complex, long term chronic illness. 21 It is to practise a form of healthcare which is rich in technical skill, yet poor in humanity, treating the patient not as a person, but rather as an object, subject or complex biological machine. 20 Such a vision of healthcare cannot by its nature describe a comprehensive or complete approach to the service of the sick. 2, 3, [10] [11] [12] On the contrary, it risks 'short changing' the patient, abandoning him/her to the experience and self-management of the sequelae of the primary pathology(ies), without a full and proper assistance in coping with them. The immediate outcomes of this approach are manifold, and include treatment failures, increased hospital admissions and rising health and social care costs. All of these consequences have the capacity to lead, as the WHO has warned, to an eventual bankrupting of health systems worldwide.
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| THE EMERGENCE OF PERSON-CENTERED HEALTH AND SOCIAL CARE
The last decade in particular has brought with it, in response to these dilemmas, an increasing recognition that chronically ill patients need far more comprehensive forms of assistance than the technoscientific approaches which continue to be favoured by EBM. This mandates the need to move away from our currently impersonal, fragmented and decontextualized approaches to the management of these conditions, towards newer models of care that are personalized, integrated and contextualized. In this way, affordable biomedical and technological advances can continue to be delivered to patients on the basis of objective clinical assessment, but within a humanistic framework of care which strives to understand the subjective experience of illness and to respond to it as effectively as possible. has remained a concept in search of a convincing empirical justification that, as we are able to see, has so far eluded it. These authors set out a broad and highly expansive vision for EBM's next quarter century, but one retaining no small measure of the tired hubris and triumphalism that characterized the initial such exhortations. 23, 24 Other leaders, such as Heneghan and his co-workers at the Centre for EBM in Oxford, 25 have published an 'EBM Manifesto' which focusses much more specifically on the need to address the systematic biases, wastages, errors and fraud in research underpinning patient care. Heneghan et al.'s focus on the continuing problems in the 'E' of EBM, is to be extended at their forthcoming 'EvidenceLive'
conference to include an additional emphasis on the dissemination of 'reliable' research and its translation into practice. 26 As might be fully anticipated by seasoned students of the EBM movement, the answer to EBM's current conceptual and methodological ills is presented by all such leaders in terms of the need for more reductionist approaches, not less, with none of the authors discussing how EBM might move forward in the direction of a more humanized account of clinical care. On the contrary, epidemiology, biostatistics and science-based grading methodologies, such as GRADE, [5] [6] [7] 9, 27, 28 remain the order of the day. Humanism in healthcare, it would therefore seem, is apparently viewed by EBM as a quaint reflection on yesteryear's medicine, a decoration that might prove useful in the modern packaging of an increasingly de-personalizing account of the care of those who suffer.
| Patient values and preferences
As a consequence, the relatively recent attempts by EBM to integrate patients' values and preferences into decision-making (two of a great many more patient factors) will continue to be "vexing" and not all will share precisely the same ethos. But far be it from the Journal to state that in the face of the demands of the chronic illness challenge, and the rise of patients as "sovereign consumers of healthcare services" increasing service quality and patient satisfaction. 22 As a result, we are likely to see a growing dominance of the comprehensive and allencompassing approach to health and social care which is PCC, and a diminishing enthusiasm for models of care, such as EBM (even in its most recent reincarnation), which remain reductive in approach and essentially resistant to the demands of the new clinical and political environment. The Journal predicts that as the relative merits of these respective models of care become subject to critical multi-agency scrutiny and are weighed in the balance, EBM will, as a direct function of its nature, be found wanting. How, then, should PCC and EBM, two movements in continued flux, interact in the interim, a question that has been posed, intermittently, during the respective stages of development of EBM and PCH, but rarely afforded systematic study? [40] [41] [42] 3.3 | EBM and PCC -Convergence or divergence of theses?
EBM and PCC, as a natural consequence of their foundational differences, inhabit different worlds. 40 This does not obviate the necessity for continued debate between them, especially given a novel willingness on the part of EBM to engage, at last, with its critics.
However, while scholarly exchange retains the potential to generate meaningful outcomes, it would appear that a divergence of these There is, of course, nothing wrong with reductionism per se, if, after we have 'dissected' the patient into his/her component organ systems and cellular/subcellular compartments, in order to study disease processes and monitor their modification by pharmacological and technological intervention, we then proceed to 'put the patient back together again'. 43 The 'magnifying glass' of reductionism has a vital and indispensable role, but so does the 'minifying glass', which allows us to see a more comprehensive picture. 44 The danger emerges when the diseased part or dysfunctional system is, as in EBM, detached from the sick person who manifests a broader illness state, which risks viewing the person as part of the disease, not the disease as part of the person. 12, 20, 22 The Journal predicts that the demands of modern medicine, most specifically in terms of the current epidemic of long term, chronic coand multimorbid, socially complex illnesses, 12 will inevitably result in the emergence of PCC as the model of choice when formulating comprehensive treatment recommendations and advice, making clinical decisions with the patient, and constructing detailed health and social care plans with the patient and his/her family. It is progress of this specific nature which will make "enduring contributions to clinical medicine and related fields", allowing PCC not to revolutionize clinical medicine, but rather to serve it.
| CONCLUSION
In a paper published within the European Journal for Person Centered
Healthcare in 2014, Post and Guyatt 45 argued that EBM offers the "optimal starting point" for PCC, rejecting the suggestion that PCH could provide an important -and urgently necessary -humanistic compass for EBM. The notion that an already comprehensive philosophy of care such as PCC could benefit from lessons in relentless technoscientific reductionism from EBM did not make immediate sense back then and neither does it do so now. Marcum, 46 for example, writing in the same journal in 2018, is clear that the reverse is in fact the case and argues that the only productive way forward is the unfolding and embedding of the more coherent principles of EBM into the broader person-centered health and social care thesis.
Referring to such an assertion, with which the JECP entirely agrees, the European Society for Person Centered Healthcare (ESPCH)
is moving forward methodologically in 2018 and beyond via the development of illnesses-specific guidance to assist clinicians in increasing the person-centeredness of the care they provide, with particular emphasis on how to address the modern phenomenon of co-and multimorbidity and its sequelae and how to respond to the patient's subjective experience of chronic illness. In developing such guidance, the Society will study the many 'evidence digests' produced by EBM 9 that may prove of relevance in this context, but with the aim of assimilation and situation within a much wider and far more developed framework for the service of the sick. In ways such as these, we will profitably move from an 'evidence-based, patient-focussed' ideology, to an 'evidence-informed, person-centered health and social care'.
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